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ABSTRACT 
The Effects of 24R, 25-Dihydroxyvitamin D3 and 24S, 25-Dihydroxyvitamin D3 on 
Phosphate Transport in Vivo 
 
by 
Yu Meng, Master of Science 
Utah State University, 2011 
 
Major Professor: Dr. Ilka Nemere 
Department: Nutrition, Dietetics and Food Sciences 
              The steroid hormone 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] rapidly 
stimulates the uptake of phosphate in isolated chick intestinal cells, while the steroid 
24,25-dihydroxyvitamin D3 [24,25(OH)2D3] inhibits the rapid stimulation by 
1,25(OH)2D3. Previous work in this laboratory has indicated that 24,25(OH)2D3 inhibits 
phosphate uptake in isolated intestinal cells and perfused duodenal loops. It is critical to 
show this effect in the whole animal to determine the presence of any confounding 
factors. Studies were therefore undertaken to determine if 24,25(OH)2D3  had a similar 
effect in vivo. 24,25(OH)2D3  has two isomers which are 24R, 25dihydroxyvitamin D3 
[24R,25(OH)2D3] and 24S, 25dihydroxyvitamin D3 [24S,25(OH)2D3]. We studied these 
two isomers separately and tested them over a time course of 1, 5, 10, 15, and 18 h after 
steroid using chicks on regular diet, but fasted, and chicks on a lower vitamin D diet. All 
chicks were anesthetized prior to surgical exposure of the duodenal loop and injection of 
a solution containing H332PO4 into the lumen. An initial time course study of phosphate 
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transport determined that 3 to 9 min of absorption in vivo was in a linear range, as judged 
by serum levels of radioactivity. Chicks were then injected with either 200 µg of 
24R,25(OH)2D3, 20 µg of 24S,25(OH)2D3, or vehicle for control groups within the same 
time course studies. We found that the isomers had different effects on phosphate 
absorption. 24R,25(OH)2D3 had a hypophosphatemic effect in vivo. The serum levels of 
radionuclide revealed hypophosphatemic effects at 1, 5, 15, and 18 h time points with a 
decrease of 20%, 42%, 39%, and 43%, respectively, (P< 0.05) compared with controls; 
chicks raised on a low vitamin D diet also showed a decrease in phosphate absorption at 
10 h time point by 33%. In contrast, 24S,25(OH)2D3 stimulated intestinal phosphate 
absorption at the 5-h time point by 64%, but had no other effects at the other time points 
tested. Because 24S,25(OH)2D3 was largely ineffective, dose-response studies were 
undertaken with only the 24R,25(OH)2D3 isomer. In comparing phosphate absorption in 
chicks fasted 18 h, and dosed with vehicle, 100 µg, 200 µg, or 300 µg of steroid 1 h prior 
to experimentation it was found that the lowest dose increased absorption to 99% of 
controls, while the 200 µg and 300 µg doses decreased phosphate absorption. 
 (48 pages) 
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PUBLIC ABSTRACT 
The Effects of 24R, 25-Dihydroxyvitamin D3 and 24S, 25-Dihydroxyvitamin D3 on  
Phosphate Transport in Vivo 
This research studied the effects of the two isomers of 24,25(OH)2D3 on 
phosphate absorption in vivo to increase our understanding of the effects of 
24,25(OH)2D3 on phosphate transport in vivo, and its two isomers. The current work 
demonstrates that 24R,25(OH)2D3 is capable of decreasing phosphate absorption after a 
1h injection in vivo and 24S,25(OH)2D3 can increase phosphate absorption after a 5h 
injection, but this stimulation disappears at time points after 5h. 
Since 24,25(OH)2D3 is made in vitamin D-replete animals, the observation that 
24R,25(OH)2D3 decreases phosphate absorption suggests that over supplementation of 
feeds with vitamin D may be counterproductive. Whether or not the unexpected 
observation that 24S,25(OH)2D3 briefly stimulates absorption off sets this inhibition is 
unknown. It is also likely that a lower level of supplementation with vitamin D would be 
adequate for bone growth. Thus, appropriate levels of vitamin D supplementation may 
result in more efficient utilization of phosphate in the diet, which would provide the 
benefits of reducing feed costs and reducing phosphorous excretion, thereby contributing 
to the sustainability of agriculture in the United States. Finally, these studies have 
implications for bone health in all animals, including humans to prevent rickets in 
children and osteoporosis in adults.  
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CHAPTER I 
INTRODUCTION 
Vitamin D is metabolized in the liver to 25-hydroxyvitamin D3, and in the kidney 
to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3 ] and 24,25-dihydroxyvitamin D3 
[24,25(OH)2D3]. 1,25(OH)2D3 is well known for its hormonal activity in diverse cell 
types, and its ability to enhance intestinal calcium and phosphate absorption. By 
comparison 24,25(OH)2D3 has not been as widely studied. However, a growing body of 
literature has indicated that 24,25(OH)2D3  has important effects in development of bone 
mass. Somjen et al. [1983] reported that 24R, 25(OH)2D3  but not 24S, 25(OH)2D3 was 
active in bone while Ono et al. [1996] reported 24, 25(OH)2D3 is found in fracture 
calluses in bone [Henry and Norman, 1978; Somjen et al., 1983; Ono et al., 1996].  
One goal in poultry production is to increase the amount of meat on animals, 
which in turn requires sufficient support of bone structure. To date, strategies for 
improving bone strength have included increasing dietary calcium and phosphate, as well 
as vitamin D. Knowing the effects of 24,25(OH)2D3  on phosphate and calcium 
absorption in vivo has great significance to approaching this goal. Previous work in our 
lab [Nemere, 1996a] indicated that 24R,25(OH)2D3  inhibits the rapid stimulation of 
calcium and phosphate transport mediated by 1,25(OH)2D3  in isolated chick intestinal 
cells and perfused duodenal loops. In addition Toffolon et al. [1975] found that 
24,25(OH)2D3  decreased calcium absorption in dogs and Maeda et al. [1987] reported 
that it caused hypocalcemia in rats. However the effects of 24,25(OH)2D3  on phosphate 
transport in vivo remain unknown [Akiko et al., 1997]. 
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The current study was undertaken to determine whether 24R, 25(OH)2D3  or 24S, 
25(OH)2D3  alters phosphate transport in the whole animal and if there is any 
confounding factor present in vivo. 
After establishing a time for linear transport in vivo, the experiments are designed 
in four parts. 
#1 Chicks were raised on regular diet with variable times of fasting before experiments. 
They were then injected with 24R,25(OH)2D3  or 24S,25(OH)2D3  at different time points 
(1, 5, 10, 15, and 18 h) before experimentation and effects on phosphate transport 
analyzed. 
#2 Chicks were raised on regular diet with a constant period of fasting before 
experimentation and they were then injected with 24R,25(OH)2D3  or 24S,25(OH)2D3  at 
different time points (1, 5, 10, 15, and 18 h) before experimentation and then the effects 
of the metabolites tested on phosphate transport. 
#3 Chicks were raised on a low vitamin D diet without a constant 18 h of fasting before 
experiments. They were then injected with 24R, 25(OH)2D3  or 24S, 25(OH)2D3  at 
different time points (1, 5, 10, 15, and 18 h) before experimentation and then the effects 
of the metabolites tested on phosphate transport. 
#4 After determining the optional time for observing steroid affects on phosphate 
transport, does-response studies were undertaken. Range finding were accomplished with 
does of 100, 200, and 300 µg 24R,25(OH)2D3. 
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CHAPTER II 
LITERATURE REVIEW 
Background 
Vitamin D was discovered because of a disease named rickets in young animals; 
in adults this condition is known as osteomalacia.  Professor Francis was the first to 
describe vitamin D deficiency as rickets in 1650. Rickets is now known as softening and 
weakening of the bone which results in leg bones bowing under the weight of children's 
upper torsos. This disease became the key to discovering vitamin D, which was 
considered a new nutritional factor [Hess, 1922; Mohr et al., 2008]. It was not initially 
realized that, unlike other vitamins, humans could synthesize vitamin D through exposure 
to UV light and did not require it in the diet, which meant vitamin D did not meet the 
definition of a vitamin. In addition, vitamin D metabolites can function through binding 
to specific protein receptors such as vitamin D receptor (VDR) or the 1,25D3-MARRS 
(membrane associated rapid response steroid binding) receptor to mediate calcium and 
phosphate transport. So 1,25(OH)2D3 is more like a hormone rather than a vitamin. 
Vitamin D is also named cholecalciferol in animals and ergocalciferol in plants 
and yeast in its inactive state. To become active cholecalciferol, it must be converted into 
25(OH)D3 in the liver where it is hydroxylated at carbon-25. Then in the kidney, 
25(OH)D3 is either hydroxylated at carbon-1 or carbon-24 to form the hormonally active 
secosteroids 1,25(OH)2D3 and 24,25(OH)2D3, respectively, to function at target organs 
such as bone, intestine and kidney. Figure 1 shows the feedback inhibition by 24, 
25(OH)2D3. 
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Fig. 1. 24, 25(OH)2D3 feedback loop. 
 
Mechanisms of biological action of  
vitamin D metabolites 
The three active metabolites of vitamin D are 25(OH)D3, 1,25(OH)2D3 and 
24,25(OH)2D3 (see Table 1 below for summary of metabolites). They play an important 
role in calcium and phosphate homeostasis in the body.  
1,25(OH)2D3 is the  most well studied metabolite of vitamin D.  A major function 
of 1,25(OH)2D3 is to enhance serum calcium and phosphate concentrations [Bachelet et 
al., 1979]. This is accomplished by its action on three organ systems.  
The first is intestine where it acts to enhance the dietary absorption of calcium and 
phosphate [Corradino and Wasserman, 1968]. Second, in the kidney, it stimulates 
reabsorption [Khanal and Nemere, 2007]. Third is in the bone to enhance the resorption 
and storage of these two minerals. The production and degradation of 1,25(OH)2D3 are 
processes regulated by feedback mechanisms resulting from ionic (Ca2+, PO4-), 
polypeptide hormones (PTH, calcitonin, FGF-23), and steroid factors [Bourdeau et al., 
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1990; Rohe et al., 2007; Khanal and Nemere, 2008]. Nemere [1996b] has found that 
modulation of calcium and phosphate transport in the epithelia by 1,25(OH)2D3 acts both 
through genomic and membrane-initiated actions. While the genomic regulation of 
phosphate homeostasis is mediated through the well-known vitamin D receptor (VDR) 
system; pre-genomic regulation involves the 1,25D3-MARRS receptor also identified as 
ERp57 and PDIA3 [Larsson and Nemere, 2003; Khanal et al., 2007; Tunsophon and 
Nemere, 2010]. In part, the nuclear action of 1,25(OH)2D3 functions through the classical 
vitamin D receptor (VDR). VDR is a member of the nuclear receptor family of 
transcription factors.  
 
Table 1. Vitamin D metabolite action summary 
 
Metabolite  Site of 
activation 
Proposed action Reference  
25(OH)D3 Liver  Increased CA2+ 
uptake in rat and 
chick duodena 
Olson and Deluca. 1969. 25-
hydroxycholecalciferol; direct effect on 
calcium transport. Science. 
165(891):405-7 
Sterling and Nemere 2005 
Seroids72:158-164 
 
1, 25(OH)D3 Kidney  Increased 
phosphate uptake 
and transport in 
intestine 
Zhao and Nemere. 2002. 1,25(OH)D3-
mediated phosphate uptake in isolated 
chick intestinal cells: effect of 24, 
25(OH)D3, signal transduction 
activators, and age. J. Cell Biochem. 
86(3): 497-508 
 
24,25(OH)D3 Kidney  Decreased 
phosphate uptake 
in presence of 1, 
25(OH)D3 in 
intestine 
Nemere. 1996a. apparent non-nuclear 
regulation of intestinal phosphate 
transport effects of 1,25-
dihydroxyvitamin D3, 24,25-
dihydroxyvitamin D3, and 25-
hydroxyvitamin D3. Endocrinology. 
137(6):2254-61 
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Upon activation by 1,25(OH)2D3, the VDR forms a heterodimer with the retinoid-
X receptor (RXR) and binds to vitamin D response elements (VDRE) on DNA resulting 
in expression or trans repression of specific gene products. These biological effects are 
achieved after a relatively long time. 
Another receptor is the 1,25D3-MARRS protein which can mediate the rapid 
action of 1,25(OH)2D3 [Nemere et al., 1994]. This separate membrane receptor was 
isolated from chick intestinal basal lateral membranes and was functionally linked to the 
rapid uptake of phosphate in intestinal cells by using ribozyme knockdown [Nemere et 
al., 2004.] A number of observations have contributed to the identification of a receptor 
different from the VDR. One of the observations is that vitamin D analogs that have 
limited ability to bind to the classical VDR can still stimulate the rapid actions analogous 
to those of 1,25(OH)2D3 [Nemere and Norman, 1988]. Steroid hormone stimulated rapid 
uptake and transport of calcium and phosphate is mediated by the 1,25D3-MARRS 
protein.  Receptor-ligand binding then activates the PKC pathway to stimulate phosphate 
uptake while the PKA pathway mediates calcium uptake [Nemere, 1996c; Rohe et al., 
2005]. 
Functions attributed to 1,25(OH)2D3 other than mineral ion homeostasis include 
regulation of gene transcription, promotion of cell proliferation, and stimulation of the 
immune system [Khanal and Nemere, 2009; Richard et al., 2010; Wu et al., 2010]. 
Olson and Deluca [1969] reported that 25(OH)D3 could increase calcium uptake 
in rat and chick duodena. Also Nemere [1996c] found that in perfused duodenal loops the 
mono-hydroxylated metabolite failed to stimulate phosphate transport at normal 
circulating levels and also abolished the stimulatory response to 1,25(OH)2D3, while at 5-
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fold lower than normal levels of 1,25(OH)2D3 the appearance of 32P in the venous 
effluent was stimulated. This may represent an adaption or protective mechanism for 
organisms experiencing vitamin D deficiency [Phadnis and Nemere, 2003]. 
The metabolite 24,25(OH)2D3 is another active metabolite of vitamin D and is 
produced when an animal is calcium, phosphate, and vitamin D replete and represents an 
important feedback loop to provide a protective mechanism against excess 1,25(OH)2D3 
[Larsson et al., 1995]. Nemere [1996b] has found that 24, 25(OH)2D3 suppresses a rapid 
action of 1,25(OH)2D3 on phosphate and calcium transport in the chick intestine. At a 
cellular level, 24,25(OH)2D3 has been found to inhibit the rapid membrane effects of 
1,25(OH)2D3 on opening of calcium channels in osteoblasts and osteosarcoma cells 
[Yukihiro et al., 1994; Khoury et al., 1995; Takeuchi and Guggino, 1996] and PKC 
activation in chick enterocytes [Nemere, 1999]. 24,25(OH)2D3  has two isomers which 
are 24R, 25Dihydroxyvitamin D3 and 24S,25-dihydroxyvitamin D3. The physiological 
effect of the vitamin D metabolite 24R,25-dihydroxyvitamin D3 on human osteoblastic 
cells was assessed. Physiological concentrations (10-9-10-8 M) of 24R, 25(OH)2D3 
significantly increased the cyclic guanosine 5'-monophosphate (cGMP) content in the 
human osteoblastic cells by approximately 200% in 5 to 15 min. In contrast, 24S, 25-
dihydroxyvitamin D3 had only a weak effect on the cGMP content, and 1,25-
dihydroxyvitamin D3 did not affect the content [Yoshimoto and Norman, 1986]. These 
observations suggest that 24R, 25(OH)2D3 has a unique activity of increasing cGMP 
content in osteoblastic cells, and that the increase in cGMP content may lead to the 
cooperative effect of 24R, 25(OH)2D3 with 1, 25(OH)2D3 on osteocalcin synthesis. These 
data support the hypothesis that 24R, 25(OH)2D3 has a physiological role in human  
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bone and mineral metabolism. 
Biological effect and mechanism of  
24,25(OH)2D3 action 
 Evidence has shown that 24,25(OH)2D3 has distinctly different biological effects 
and mechanisms from 1,25(OH)2D3. 24,25(OH)2D3 inhibits the rapid stimulation by 
1,25(OH)2D3. Earlier work in the Nemere lab has indicated that a cellular binding protein 
for 24,25(OH)2D3 is the enzyme the catalase [Larsson et al., 2006]. A functional 
consequence of 24,25(OH)2D3 binding to catalase was found to be a decrease in enzyme 
activity, with concomitant increase in H2O2 production [Nemere et al., 2006]. One 
mechanism of inhibition was then found to be oxidation of the 1,25D3-MARRS receptor 
and inhibition of 1,25(OH)2D3 binding [Nemere et al., 2006]. Antioxidant diets nearly 
doubled phosphate absorption in vivo [Nemere et al., 2006]. Peery and Nemere [2007] 
then proved the hypothesis that anti-oxidant conditions, such as an anti-catalase antibody 
or excess exogenous catalase protein, could block the inhibitory action of 24,25(OH)2D3, 
whereas pro-oxidant conditions, such as a triazole inhibitor of catalase activity, could 
mimic the inhibitory action of the secosteroid. It was further recognized that H2O2 could 
also influence the signal transduction pathway beyond ligand binding to the 1, 
25(OH)2D3-MARRS receptor [Peery and Nemere, 2007]. 
The model for the interaction between the 1,25D3-MARRS receptor and catalase 
is described in Fig. 2. Upon binding 1,25(OH)2D3, the 1,25D3-MARRS receptor 
dimerizes and increases signal transduction through PKA for enhanced calcium uptake 
and PKC for enhanced phosphate uptake. Feedback inhibition of this stimulatory pathway 
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is initiated when 24,25(OH)2D3 binds to catalase, thereby decreasing enzymatic activity. 
The increased H2O2 levels are known to inhibit stimulated ion uptake and in this way the  
rapid stimulation by 1, 25(OH)2D3 is inhibited by 24, 25(OH)2D3. 
Phosphate absorption and bone health 
One of the most important roles of vitamin D is to maintain skeletal phosphate 
balance by promoting phosphate absorption in the intestines, promoting bone resorption 
by increasing osteoclast number, maintaining calcium and phosphate levels for bone 
formation, and allowing proper functioning of parathyroid hormone to maintain serum 
calcium and phosphate levels [Tatsuo, 2004; Adams and Hewison, 2010].  
 
  
Fig. 2. Model of endocrine feedback of 24, 25(OH)2D3 on the rapid action of 
1,25(OH)2D3. 
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The reason why vitamin D deficiency can result in lower bone mineral density 
and an increased risk of bone loss (osteoporosis) or bone fracture is because a lack of 
vitamin D alters mineral metabolism in the body [Lips, 2010]. This suggests that 
phosphate plays a very important role in bone health either in bone formation and bone 
mineral density.  
Phosphates are normally absorbed from food and are important chemicals in the 
body. They are involved in cell structure, energy transport and storage, vitamin function, 
and numerous other processes essential to health [Holick, 2005]. White et al. [2011] 
tested the effect of oral phosphate and alendronate on bone mineral density when given as 
adjunctive therapy to growth hormone replacement (GHR) in adult growth hormone 
deficiency [Marry et al., 1976]. Phosphate and alendronate therapy given in combination 
with GHR confer an advantage in terms of bone mineral density (BMD) increase. 
Phosphate appears to exert its effect by increasing PTH target-organ action, whereas 
alendronate acts primarily through reduction in bone resorption [Nemere, 2007]. It was 
also recently reported that phosphorus has a unique role in bone formation and osteocyte 
maturation recently. In addition phosphate levels in blood are also very important to heart 
and kidney disease. And 24,25(OH)2D3 as a hormone that mediates phosphate absorption  
is also important in bone health. 
Hypothesis 
The hypothesis to be tested is that 24,25(OH)2D3 decreases phosphate transport in 
vivo.  The experiments conducted to test the hypothesis: 
1. Determining a period of linear phosphate absorption. 
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2. Determining phosphate absorption with variable times of fasting in chicks on a normal 
vitamin D diet.  
3. Determining phosphate absorption after constant 18 h fasting in chicks on a normal 
vitamin D diet. 
4. Determining phosphate absorption with chicks on a low vitamin D diet, no fasting. 
5. Dose-response studies of 24R,25(OH)2D3 on phosphate absorption with chicks on a  
regular diet but fasted. 
Thesis Proposal 
 With sufficient study results suggesting that there are pregenomic actions of 24, 
25(OH)2D3 in vitro, I tested the hypothesis that 24, 25(OH)2D3 can also alter phosphate 
transport in the whole animal and if its two isomers 24R,25(OH)2D3 and 24S,25(OH)2D3 
have the same effects on phosphate transport in vivo. The specific aims were as follows: 
1. To determine the effect of 24R,25(OH)2D3 on phosphate transport in chicks raised on 
regular diet with variable or constant times of fasting before experiments. 
2. To determine the dose-response of 24R,25(OH)2D3 on phosphate transport in chicks 
raised on regular diet with a constant interval of fasting before experiments 
3. To determine the effect of 24R,25(OH)2D3 on phosphate transport in chicks raised on 
low vitamin D diet with variable times of fasting before experiments. 
4. To determine the effect of 24S,25(OH)2D3 on phosphate transport in chicks raised on 
regular diet with a variable or a constant interval of fasting before experiments. 
5. To determine the effect of 24S,25(OH)2D3 on phosphate transport in chicks raised on 
low vitamin D diet with variable times of fasting before experiments. 
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CHAPTER III 
MATERIALS AND METHODS 
Animals and surgical procedures 
  Utah State University Institutional Animal Use and Care Committee approved all 
procedures. White leghorn cockerels were obtained on the day of hatch (Privett Hatchery, 
Portales, NM) and raised on a regular diet (800 IU vitamin D /kg) or low vitamin D diet 
(200 IU vitamin D/kg) for 3 weeks prior to experimentation. On the day of use, chicks 
were anesthetized with 0.3 ml Chloropent /100g of body weight (Fort Dodge 
Laboratories, Fort Dodge, IA). The abdominal cavity was surgically opened and the 
duodenal lumen injected with 1 ml Grey’s Balanced Salt Solution (GBSS, 119 mM 
NaCL, 4.96 mM KCl, 0.22 mM KH2PO4, 0.89 mM Na2HPO4, 1.03 mM MgCl26H2O, 
0.28 mM MgSO4 7H2O2, 0.9 mM CaCl2 2H2O buffered to PH 7.4) mixed with 1µCi 
H332PO4 (GBSS; H332PO4 1000:1).  An initial time course of phosphate transport 
determined that 5 min transport period was within a linear range. After 5 min of 
transport, blood was collected by decapitation before preparation of serum, and 
radioactivity determined by liquid scintillation spectrophotometry.  
 In one set of experiments chicks were anesthetized with ether. Although no 
significant differences were eventually found between results with ether or chloropent  
anesthesia, ether was  not used because of potential oxidant formation. 
Time courses studies 
The chicks were divided into three groups in each time course study. They were 
injected with vehicle (1:1 ethanol: propanediol), 200 µg 24R,25(OH)2D3 [Maeda et al., 
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1987] in vehicle, or 20 µg 24S,25(OH)2D3 [Ishizuka et al. 1984] in vehicle several hours 
before experimentation. The extended time course points were 1, 5, 10, 15, and 18 h. 
During these time points the chicks were fed water only (the chicks which were on  
regular diet had an 18 h fast before experiments).  
Effect of 24R,25(OH)2D3 or 24S,25(OH)2D3 on 32P  
uptake by intestine 
After waiting for 5 min for phosphate transport, the blood was collected after 
decapitation. The blood was collected in tubes, labeled, sealed and stored at 4oC 
overnight for clot separation from serum. An aliquot of serum (200µl) was pipetted into 
vials and scintillation fluid added. 32P was then determined by using liquid scintillation  
spectrophotometry.  
Dose-response studies 
 Chicks were divided into four groups with a constant fasting period of 18 h. They 
were injected with vehicle (1:1 ethanol: propanediol), 100 µg 24R,25(OH)2D3 in vehicle, 
200 µg 24R,25(OH)2D3 in vehicle or 300 µg 24R,25(OH)2D3 in vehicle 1 hour before  
experimentation.  
Statistical analyses 
Statistical comparisons between treatment groups were made using ANOVA.  
Statistical significance was set at P<0.05. Results are expressed as Mean + SEM for each 
set of independent experiments. See Appendix B for a detailed summary of statistical 
measures.
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CHAPTER IV 
RESULTS 
Linear transport range (3-12 min) 
Figure 3 shows the results of experiments designed to determine a suitable time 
point for 32P transport in intestine. Time course studies on 32P uptake in chick intestine 
were undertaken with a range of time points (3, 6, 9 and 12 min). The results show a 
linear increase of 32P in serum (R2 =0.9757) from 3 to 9 min, reflecting absorption, as 
judged by serum levels of radioactivity. At 12 min there was a decrease in 32P level in 
serum, most likely due to a decrease in available phosphate. Since phosphate uptake is 
stably increasing from 3 to 9 min, 5 min was chosen as the phosphate transport time in  
the subsequent experiments. 
Phosphate absorption with variable times of   
fasting in chicks on a normal vitamin D diet 
Figure 4 illustrates the results of experiments designed to test whether 
24R,25(OH)2D3 has a hypophosphatemic effect in vivo. In this series of experiments, 
chicks were raised on regular diet for three weeks. Prior to the day of use, chicks (n=12) 
in the control groups (absence of hormone) were injected with vehicle (1:1 ethanol: 
propanediol) at selected hours before experimentation, and at the same time the chicks 
(n=12) of the treated groups (with hormone) were injected with 24R,25(OH)2D3 in 
vehicle. Before experimentation, chicks were only fed water. After the selected hours, all 
chicks were anesthetized prior to surgical exposure of the duodenal loop and injection of 
a solution containing H332PO4 into the lumen. According to the initial time course study,  
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Fig. 3. Time course study of 32P transport in chick intestine. 18 chicks were divided into 
four groups. They were anesthetized with 0.3 ml chloropent /100g of body weight. The 
abdominal cavity was surgically opened and the duodenal loop injected with 1 ml GBSS 
containing 1µCi of 32P. After waiting for (1) T=3 min (n=6); (2) T=6 min (n=6); (3) T=9 
min (n=6); (4) T=12 min (n=3), blood was collected by decapitation. Serum from the 
samples was obtained after storage at 4 C for several hours to allow clot formation and 
radioactivity determined by liquid scintillation spectrophotometry. Data are presented as 
mean + SEM. 
 
 
after 5min of transport, serum levels of radioactivity were used to determined phosphate 
absorption.The results show 1 h and 5 h after injection of 24R,25(OH)2D3 there was no 
difference in phosphate absorption between the control and treated groups. A slight 
inhibition was found at the10-hour time point; and a dramatic response was obtained at 
15 and 18 h (Fig. 4) after steroid. Statistical comparison by ANOVA confirmed that 
phosphate absorption in chick intestine was not different between control and treated 
groups at 1, 5, and 10 time points, but at the 15- and 18-hour time points phosphate 
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transport was significantly decreased by 24,25(OH)2D3 (P<0.05) by 33% and 25%, 
respectively.  Figure 4 further reveals that variable fasting times had an effect on 
phosphate absorption, since the control group of 15 h was 2990.8 ± 431.6 cpm/200µl 
serum while the 1 h was only 1184.7 ± 121.9 cpm/200µl serum, suggesting that food 
consumption in general maybe a confounding factor for phosphate transport in vivo. 
Figure 5 depicts the effects of 24S,25(OH)2D3 on phosphate transport in vivo with 
variable fasting times. Conditions were the same as Fig. 4, but instead of injecting 
24R,25(OH)2D3, 24S,25(OH)2D3 was injected prior to experimentation. No differences 
 
 
Fig. 4. Time course of 24R,25(OH)2D3 effect on 32P transport in chick intestines with 
variable times of fasting. Chicks were divided into five groups, 24 in each group and each 
group further divided into two groups, control (C, n=12) and treated (D, n=12). They 
were raised on a regular diet (800 IU vitamin D /kg) generally for 3 weeks prior to 
experimentation. On the day of use, chicks in control groups were injected with vehicle at 
the indicated hours before experimentation and at the same time the chicks of the treated 
groups injected with 24R,25(OH)2D3 in vehicle. After selected hours (1, 5, 10, 15, and 
18h) of fasting, they were anesthetized with a 0.3 ml chloropent /100g of body weight. 
The abdominal cavity was surgically opened and the duodenal loop injected with1 ml 
GBSS containing 1µCi of 32P. After 5min, blood was collected by decapitation. Serum 
from the samples was obtained after storage at 4 C for several hours to allow clot 
formation and radioactivity determined by liquid scintillation spectrophotometry. Data 
are presented as mean + SEM. C, vehicle control; D, 200µg 24R,25(OH)2D3. 
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were observed between control and treated groups at any of the time points (P>0.2). Also, 
in this figure, it is evident that there was a large range in phosphate absorption from 1 h 
to 15 h, which further indicates that diet is one of the confounding factors in phosphate 
transport. General nutrient uptake may affect gastrointestinal hormones (GI hormone), 
which may increase the phosphate uptake. The increase in phosphate absorption in 
controls at the later time points may be due to an increase in transporters at the brush 
border surface. 
 
 
 
 Fig. 5. Time course of 24S,25(OH)2D3 effect on 32P transport in chick intestines with 
variable times of fasting. Chicks were divided into two groups, control and treated,  60 in 
each group and each group further divided into four time groups, 1h (n=3), 5 (n=3), 10 
(n=30), 15 (n=30). They were raised on a regular diet (800 IU vitamin D /kg) generally 
for 3 weeks prior to experimentation. On the day of use, chicks in control groups were 
injected with vehicle at the indicated times before experimentation, and at the same times 
the chicks of the treated groups were injected with 24S,25(OH)2D3 in vehicle. After 
selected hours (1, 5, 10, and 15 h) of fasting, they were anesthetized with 0.3 ml 
chloropent /100g of body weight. The abdominal cavity was surgically opened and the 
duodenal loop injected with1 ml GBSS containing 1µCi 32P. After 5 min, blood was 
collected by decapitation. Serum from the samples was obtained after storage at 4 C for 
several hours to allow clot formation and radioactivity determined by liquid scintillation 
spectrophotometry. Data are presented as mean + SEM. C, vehicle control; D, 20µg 
24S,25(OH)2D3. 
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Phosphate absorption after constant 18 h fasting  
in chicks on a normal vitamin D diet 
Clearly the variable times of fasting had an impact on phosphate absorption (Figs. 
4, 5). To exclude this confounding factor shown in Fig. 4 and Fig. 5, chicks in the next 
series of experiments were raised on regular diet for three weeks but prior to use, they 
were all fasted for 18 h before experimentation. In these studies, chicks were injected 
with 24R,25(OH)2D3 or vehicle. 
Fig. 6. Time course of 24R,25(OH)2D3 effect on 32P transport in chick intestines with a 
constant 18 hours of fasting. Chicks were divided into six groups, control (n=17), 1h 
(n=7), 5 h (n=10), 10h (n=9), 15h (n=13) and 18h (n=15). They were raised on a regular 
diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use, 
chicks in control groups were injected with vehicle 18 hours before experimentation at 
the same time the chicks of the treated groups began fasting and were served only water. 
At the indicated hours before experimentations chicks of the treated groups were injected 
with 24R,25(OH)2D3 in vehicle. After selected hours (1, 5, 10, 15 and 18 h) they were 
anesthetized with 0.3 ml /100g of body weight chloropent. The abdominal cavity was 
surgically opened and injected with1 ml GBSS containing 1µCi 32P in the duodenal loop. 
After 5 min of absorption, blood was collected by decapitation. Serum from the samples 
was obtained after storage at 4 C for several hours and radioactivity determined by liquid 
scintillation spectrophotometry. Data are presented as mean + SEM. *P<0.05, relative to 
vehicle controls. 
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Compared with Figs. 4 and 5, the range of 32P absorption is considerably less than 
that depicted in Fig. 6. In addition, the 1 h and 5 h steroid treated groups also showed a 
significant decrease (P<0.02) in phosphate transport relative to controls, instead of only at 
15 h and 18 h. At 10 h 24R,25(OH)2D3 again failed to inhibit phosphate transport even 
after 18 h of constant fasting before experimentation. As seen previously (Fig. 4), 
however, 24R,25(OH)2D3 inhibited phosphate absorption at the 15- and 18-h time points 
(Fig. 6) . 
 
 
 
Fig. 7. Time course of 24S,25(OH)2D3 effect on 32P transport in chick intestines with 
constant 18 hours of fasting. Chicks were divided into six groups, control (n=12), 1 h 
(n=9), 5 h (n=10), 10 h (n=8), 15 h (n=8) and 18 h (n=8). They were raised on a regular 
diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use, 
chicks in control groups were injected with vehicle 18 h before experimentation and at 
the same time the chicks of the treated groups began fasting and were only fed on water. 
At selected hours before experimentation chicks of the treated groups were injected with 
24S,25(OH)2D3 in vehicle. After selected hours (1, 5, 10, 15, and 18 h) they were 
anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was 
surgically opened and the duodenal lumen injected 1 ml GBSS containing 1µCi 32P. After 
5min of absorption, blood was collected by decapitation. Serum from the samples was 
obtained after storage at 4 C for several hours and radioactivity determined by liquid 
scintillation spectrophotometry. Data are presented as mean + SEM.   
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In Fig. 7, a slight stimulation by 24S,25(OH)2D3 was found in the 1 h and 15 h 
groups but this was still not significant when compared by ANOVA (P>0.05).  After 18 h 
constant fasting in chicks, 24S,25(OH)2D3 also failed to alter in phosphate transport in 
vivo. 
 
Dose-response studies of 24R,25(OH)2D3 
After 18 h constant fasting in chicks, 24S,25(OH)2D3 failed to alter phosphate 
transport in vivo (Fig. 7) whereas 24R,25(OH)2D3 decreased phosphate transport 1, 5, 15, 
and 18 h after injection (Fig. 6). After determining the optimal time for observing steroid 
affects on phosphate transport, dose-response studies of  24R,25(OH)2D3 were 
undertaken. Chicks were injected with vehicle (1:1 ethanol: propanediol), 100 µg 
24R,25(OH)2D3 in vehicle, 200 µg 24R,25(OH)2D3 in vehicle or 300 µg 24R,25(OH)2D3 
in vehicle respectively 1 h before experimentation, and phosphate absorption was 
determined from serum by liquid scintillation spectrophotometry. Results are shown in 
Fig. 8. ANOVA confirmed that the 100 µg group exhibited an increased phosphate 
absorption compared with control group (P<0.05). In the 100 µg group, phosphate 
absorption increased by 99% compared with the chicks in control group. The stimulation 
may be because lower level of 24R,25(OH)2D3 could affect Parathyroid hormone (PTH) 
secretion [Nemere, 1996b] which further stimulates phosphate absorption. 
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Fig. 8. Dose-response study of 24R,25(OH)2D3 effect on 32P transport in chick intestines 
with a constant 18 hours of fasting. Chicks were raised on a regular diet (800 IU vitamin 
D /kg) for 3 weeks prior to experimentation. Chicks were divided into four groups, 
control (n=5), 100 µg (n=3), 200 µg (n=3) and 300 µg (n=). They were injected with 
vehicle (1:1 ethanol: propanediol), 100 µg 24R,25(OH)2D3 in vehicle, 200 µg 
24R,25(OH)2D3 in vehicle or 300 µg 24R,25(OH)2D3 in vehicle, respectively, 1 h before 
experimentation. On the experimentation they were anesthetized with 0.3 ml chloropent 
/100g of body weight. The abdominal cavity was surgically opened and injected with1 ml 
GBSS containing 1µCi 32P in the duodenal loop. After 5min of absorption, blood was 
collected by decapitation. Serum from the samples was obtained after storage at 4 C for 
several hours and radioactivity determined by liquid scintillation spectrophotometry. Data 
are presented as mean + SEM. *P<0.05, relative to vehicle controls. 
 
Phosphate absorption with chicks on a low  
vitamin D diet, no fasting 
To further exclude the diet’s effect on phosphate absorption, chicks in this series 
of experiments were raised on a low vitamin D diet for 3 weeks before the experiments 
with no fasting before experimentation. Previous experiments showed 24R,25(OH)2D3 
has a hypophosphatemic effect in vivo after 1, 5, 15, and 18 h following injection with 18 
h constant fasting before experimentation. Figure 9 shows the results of absorption in 
chicks raised on a low vitamin D diet, and ANOVA confirmed that the 1-h, 5-h, 10-h, and 
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15-h groups all exhibited a decreased phosphate absorption compared with control groups 
(P<0.02). In the 1-h group, phosphate absorption decreased by 50% compared with the 
chicks that were raised on regular diet in which phosphate transport decreased by 30%. 
However the latter decrease was not significantly different than control, which indicates 
that the vitamin D level in the diet is one of the confounding factors that may affect 
phosphate transport in vivo. 
 
 
Fig. 9. Time course of 24R,25(OH)2D3 effect on 32P transport in chick intestines in chicks 
raised on a low vitamin D diet but not fasted. Chicks were divided into six groups, 
control (n=12), 1 h (n=6), 5 h (n=9), 10 h (n=9), 15 h (n=10) and 18 h (n=8). They were 
raised on a low vitamin D diet (200 IU vitamin D /kg) for 3 weeks prior to 
experimentation. On the day of use, chicks of control groups were injected with vehicle 
18 h before experimentation. At selected hours (1, 5, 10, 15, and 18 h) before 
experimentation chicks of the treated groups were injected with 24R,25(OH)2D3 in 
vehicle. On the day of experimentation they were anesthetized with 0.3 ml chloropent 
/100g of body weight. The abdominal cavity was surgically opened and injected with 1 
ml GBSS containing 1µCi 32P into the lumen of duodenal loop. After 5min, blood was 
collected by decapitation. Serum from the samples was obtained after storage at 4 C for 
several hours and radioactivity determined by liquid scintillation spectrophotometry. Data 
are presented as mean + SEM. * P<0.05, relative to vehicle controls. 
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Figure 10 illustrates the results of comparable experiments with chicks fed a low 
vitamin D diet, and injected with 24S,25(OH)2D3 or vehicle. 24S,25(OH)2D3 stimulated 
the phosphate transport at the 5-h time point after injection (P<0.05), but no significant 
differences were observed at the other time points. 
 
 
 
 
Fig. 10. Time course of 24S,25(OH)2D3 effect on 32P transport in chicks raised on a low 
vitamin D diet but not fasted. Chicks were divided into six groups, control (n=9), 1 h 
(n=9), 5 h (n=9), 10 h (n=8), 15 h (n=9) and 18 h (n=10). They were raised on a low 
vitamin D diet (200 IU vitamin D /kg) generally for 3 weeks prior to experimentation. On 
the day of use, chicks of control groups were injected with vehicle 18 h before 
experimentation. And the treated groups were injected with 24S,25(OH)2D3 in vehicle1, 
5, 10, 15, and 18 h before experimentation. After selected hours (1, 5, 10, 15, and 18 h), 
they were anesthetized with a 0.3 ml chloropent /100g of body weight. The abdominal 
cavity was surgically opened and injected with 1 ml GBSS containing 1µCi of 32P into 
the lumen of duodenal loop. After 5 min, blood was collected by decapitation. Serum 
from the samples was obtained after storage at 4 C for several hours and radioactivity 
determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. 
* P<0.05, relative to vehicle controls. 
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CHAPTER V 
DISSCUSSION 
The current work demonstrates that 24R,25(OH)2D3 is capable of decreasing 
phosphate absorption after a 1-h injection in vivo and 24S,25(OH)2D3 can increase 
phosphate absorption after a 5-h injection, but this stimulation disappears at the time 
points tested after 5 h. 
In previous reports, the enzyme catalase was proved to be a cellular binding 
protein for 24,25(OH)2D3 [Larsson et al., 2006]. Catalase activity could be inhibited by 
24,25(OH)2D3 and production of H2O2 increased in intestinal cells [Nemere et al., 2006]. 
Hydrogen peroxide, in turn, oxidizes thiols within the 1,25D3-MARRS receptor to 
decrease binding of 1,25(OH)2D3, and also inhibit the rapid stimulation of the protein 
kinase C signaling pathway [Peery and Nemere, 2007].  
In the present study, it was found that the two isomers of 24,25(OH)2D3 had 
different effects on phosphate transport in vivo suggesting that the inhibitory effect might 
be mainly performed by 24R,25(OH)2D3 while 24S,25(OH)2D3 might have another 
receptor or in some manner stimulate other pathways to mediate phosphate absorption in 
vivo. Somjen et al. [1983] reported that 24R,25(OH)2D3 but not 24S,25(OH)2D3 was 
active in bone. However, in this work, 24S,25(OH)2D3 was found to be active in chick 
intestine in vivo and increased phosphate transport at 5h but this effect disappeared at 10 
h and later time points. 
Another observation is 24R,25(OH)2D3 decreased phosphate absorption after 1 h 
indicating that the phosphate inhibition might not occur because of 24R,25(OH)2D3 
binding to catalase or blocking the1,25D3-MARRS receptor. Previous work in the 
	   25 
perfused duodenal loop system proved that the antagonism of the stimulatory effect of 
1,25(OH)2D3  by 24,25(OH)2D3 was seen 10 min after the onset of perfusion [Nemere, 
1996b]. There might be a separate nuclear receptor for 24,25(OH)2D3 which could induce 
genomic change in cells resulting in a decreased absorption of phosphate after 1 h. 
Another mechanism maybe catalase binding to STAT3 [Ndubuisi et al., 1999]. In 
addition, this effect disappeared after 18 h. Alternatively, 24R,25(OH)2D3 might mediate 
the production of separate hormones that regulate phosphate absorption, such as 
fibroblast growth factor-23 (FGF 23) which is a recently identified member of the FGF 
family involved in phosphate homeostasis [Razzaque et al., 2005]. 
Early work with isolated cells or perfused duodenal loops could not completely 
apply in vivo because of potential confounding factors that have yet to be determined. In 
the current work using individual chicks and studies of the effects of 24,25(OH)2D3 in 
vivo, we found that the duration of fasting and vitamin D level in the diet were two 
factors that had a major influence on phosphate absorption. The chicks fed on a low 
vitamin D diet showed more significant decreases in phosphate transport than chicks fed 
on regular diet. While chicks on the regular diet but with different fasting times had a 
large range of serum phosphate values between each time point. The greater phosphate 
absorption could be due to a generalized increase in nutrient absorption, in which 
phosphate is bound to other components. Another possibility could be due to the release 
and action of GI hormones. Also, the dose response experiment suggested low level of 
24R,25(OH)2D3 could stimulate phosphate absorption while a higher level could not 
increase phosphate absorption but decreased it instead. The stimulation could due to a 
low level of 24R,25(OH)2D3 that may increase PTH secretion which led to increasing 
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phosphate absorption in vivo [Nemere and Szego, 1981a; Nemere and Szego, 1981b]. As 
noted earlier, the higher cpms at longer fasting times might be due to increased phosphate 
transporters appearing at the brush border membrane. 
This research increases our understanding of the effects of 24,25(OH)2D3 on 
phosphate transport in vivo, and its two isomers. By understanding the action of these 
two isomers, progress will be made in enhancing phosphate absorption in production 
animals to supply the minerals for adequate bone growth. Moreover, more efficient 
utilization of phosphate in the diet will provide the benefits of reducing feed costs and 
reducing phosphorous excretion, thereby contributing to the sustainability of agriculture 
in the United States. Also these studies have implications for bone health in all animals, 
including humans to prevent rickets in children and osteoporosis in adults. 
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Appendix A. Abbreviations
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µCi……………………..Microcurie, a term used to quantify radioactivity 
µg………………………Micrograms 
µl……………………….Microliter 
1,25(OH)2D3…..………..1, 25-dihydroxyvitamin D3  
1,25D3-MARRS………..1,25-dihydroxyvitamin D3 membrane-associated, rapid-response 
receptor                             steroid-binding protein  
 
24R,25(OH)2D3…..……24R, 25-dihydroxyvitamin D3  
24S,25(OH)2D3…..……24S, 25-dihydroxyvitamin D3  
25(OH)2D3…..………….25-hydroxyvitamin D3  
32P……………………….Radioisotope of phosphorous from abbreviated notation of           
         H332PO4 
 
ANOVA…………………Analysis of Variants 
Ca2+……………………..Calcium 
cpm/ µg………………….Counts per minute over micrograms of protein 
GBSS……………………Gey’s Balanced Salt Solution 
H2O2……………………..Hydrogen peroxide 
mM………………………Millimolar. 
P………………………….P-value statistical measure 
PKA………………………Protein Kinase A 
PKC………………………Protein Kinase C 
SEM………………………Standard Error of Mean 
T…………………………..Abbreviation of Time 
VDR……………………….Vitamin D Nuclear Receptor 
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Table A. ANOVA for figure 4. Time course of 24R,25(OH)2D3 effect on 32P transport in 
chick intestines with variable times of fasting. 
Time 1h C 1h D 5h C 5h D 10hC 10hD 15hC 15hD 18hC 18hD 
Average  1184 1137 1272 1281 1954 1538 2990 2016 2341 1755 
SE 121.8 171.5 222.1 232.5 265.2 230.3 431.6 73.7 207.3 284.9 
DF 12 12 12 12 12 12 12 12 12 12 
T test  0.22  0.028  1.19  2.23  1.67 
P value  P>0.1  P>0.1  P>0.
1 
 P<.0
5 
 P<.0
5 
 
 
Table B. ANOVA for figure 5. Time course of 24S,25(OH)2D3 effect on 32P transport in 
chick intestines with variable times of fasting. 
Time 1h C 1h D 5h C 5h D 10h C 10hD 15h C 15h D 
Average  1043.2 1081.6 1081.6 1203.2 1999.4 2184 2105.8 2015.74 
S.E. 332.8 128 371.2 140.8 280.96 220.96 322.56 289.68 
DF 3 3 3 3 30 30 30 30 
T test  0.11  0.31  0.52  0.21 
P value  P>0.05  P>.05  P>.05  P>0.05 
 
 
Table C. ANOVA for figure 6. Time course of 24S,25(OH)2D3 effect on 32P transport in 
chick intestines with a constant 18 hours of fasting. 
Time Control 1 h 5h 10h 15h 18h 
Average  318.64 419.67 342.78 299.80 351.40 303.98 
Standard Error 72.87 109.46 43.15 105.57 50.85 64.10 
DF 12 9 10 8 8 8 
T test  0.77 0.28 0.14 0.37 0.15 
P value  P>0.2 P>0.2 P>0.2 P>0.2 P>0.2 
 
 
Table D. ANOVA for figure 7. Time course of 24S,25(OH)2D3 effect on 32P transport in 
chick intestines with a constant 18 hours of fasting. 
Time Control 1 h 5h 10h 15h 18h 
Average  318.64 419.67 342.78 299.80 351.40 303.98 
Standard Error 72.87 109.46 43.15 105.57 50.85 64.10 
DF 12 9 10 8 8 8 
T test  0.77 0.28 0.14 0.37 0.15 
P value  P>0.2 P>0.2 P>0.2 P>0.2 P>0.2 
 
 
Table E. ANOVA for figure 8. Dose-response of 24R,25(OH)2D3 effect on 32P transport 
in chick intestines at 1h. 
Time Control 100 µg 200 µg 300 µg 
Average  131.12 261.20 98.90 85.33 
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Standard Error 18.09 22.19 17.7 16.37 
DF 5 3 3 3 
T test  3.32 1.15 1.86 
P value  P<0.05 P>0.05 P>0.05 
 
 
Table F. ANOVA for figure 9. Time course of 24R,25(OH)2D3 effect on 32P transport in 
chick intestines without fasting on a low vitamin D diet. 
Time Control 1 h 5h 10h 15h 18h 
Average  134.03 68.93 79.43 89.47 77.90 131.35 
Standard Error 17.94 6.28 16.38 12.17 13.28 45.04 
DF 12 6 9 9 10 8 
T test  3.66 2.35 2.16 2.8 0.06 
P value  P>0.2 P<0.05 P<0.05 P<0.05 P>0.2 
 
 
Table G. ANOVA for figure 10. Time course of 24S,25(OH)2D3 effect on 32P transport in 
chick intestines without fasting on a low vitamin D diet. 
Time Control 1 h 5h 10h 15h 18h 
Average  218.64 250.22 359.5 223.75 254.44 270.8 
Standard Error 40.00 42.63 52.03 66.85 53.05 52.08 
DF 9 9 9 8 9 10 
T test  1.15 2.15 1.5 1.45 0.99 
P value  P>0.2 P<0.05 P>0.2 P>0.2 P>0.2 
 
